Local Anesthetics Practice Questions

Q: Which of the following is referred to as the 'chemical tourniquet'?

Adrenaline. **Explanation:** **Why Adrenaline is the Correct Answer:** Adrenaline (Epinephrine) is known as a **'chemical tourniquet'** because of its potent **α1-adrenergic agonist** activity. When added to local anesthetics (LAs), it causes significant vasoconstriction at the site of injection. This action mimics a physical tourniquet by: 1. **Decreasing systemic absorption:** It keeps the anesthetic localized, thereby reducing the risk of systemic toxicity (LAST). 2. **Increasing duration of action:** By slowing down the removal of the drug by the bloodstream, the anesthetic remains in contact with the nerve for a longer period. 3. **Providing a bloodless field:** The vasoconstriction reduces surgical bleeding. **Why Other Options are Incorrect:** * **Hyaluronidase:** This is known as the **'spreading factor.'** It breaks down hyaluronic acid in the connective tissue, increasing the permeability of the tissue. It is used to enhance the diffusion and onset of local anesthetics (commonly in ophthalmic blocks), which is the functional opposite of a tourniquet. * **Option C and D:** Since Adrenaline and Hyaluronidase have antagonistic effects on drug localization, they cannot both be referred to as a chemical tourniquet. **High-Yield NEET-PG Pearls:** * **Standard Concentration:** Adrenaline is typically used in a concentration of **1:200,000** (5 µg/mL) with local anesthetics. * **Contraindications:** Never use Adrenaline in blocks involving **end-arteries** (e.g., fingers, toes, tip of the nose, penis, and pinna of the ear) due to the risk of ischemia and gangrene. * **Maximum Dose:** The addition of Adrenaline allows for a higher maximum permissible dose of LAs (e.g., Lignocaine dose increases from 3 mg/kg to **7 mg/kg**).

Q: Which of the following nerve fibers are most susceptible to the action of local anesthetics?

C fibers. **Explanation:** The susceptibility of nerve fibers to local anesthetics (LAs) is governed by the **size of the fiber** and the **presence of myelin**. Generally, smaller fibers and myelinated fibers are blocked more easily than larger, unmyelinated ones. **Why C fibers are the correct answer:** C fibers are the **smallest in diameter** (0.4–1.2 μm) and are **unmyelinated**. While myelination usually increases sensitivity (as seen in B fibers), the extremely small diameter of C fibers allows the local anesthetic to reach a critical blocking concentration across the axonal membrane much faster than in larger fibers. They carry slow pain and temperature sensations. **Analysis of Incorrect Options:** * **A fibers:** These are large, myelinated fibers. Due to their large diameter, they are the most resistant to LA blockade. They are subdivided into alpha (motor), beta (touch/pressure), gamma (muscle spindles), and delta (fast pain). * **B fibers:** These are small, myelinated preganglionic autonomic fibers. In clinical practice, **B fibers are often the first to be blocked** because they are myelinated and small. However, in terms of absolute sensitivity to the drug concentration, C fibers are traditionally considered the most susceptible. * **D fibers:** This is a distractor; there is no "D fiber" in the Erlanger-Gasser classification of nerve fibers. **NEET-PG High-Yield Pearls:** 1. **Order of Blockade (Clinical):** B fibers (Autonomic) > A-delta & C fibers (Pain/Temp) > A-gamma & A-beta (Touch/Pressure) > A-alpha (Motor). 2. **The "3-Node Rule":** For myelinated fibers, at least **three successive Nodes of Ranvier** must be exposed to the LA to interrupt impulse propagation. 3. **Differential Block:** This is the clinical phenomenon where different nerve functions are lost at different times (e.g., losing pain sensation while retaining motor function).

Q: Which of the following local anesthetics is used in circumcision?

1% lignocaine without adrenaline. **Explanation:** The primary principle in choosing a local anesthetic for circumcision is the avoidance of vasoconstrictors. **1. Why 1% Lignocaine without Adrenaline is correct:** The penis is an anatomical structure supplied by **end-arteries**. The use of adrenaline (epinephrine) causes intense vasoconstriction of these terminal vessels. In the case of the penis, this can lead to prolonged ischemia, resulting in **gangrene and necrosis** of the distal tissue. Therefore, "plain" lignocaine is mandatory. 1% concentration is preferred over 2% to minimize the risk of systemic toxicity while providing adequate anesthesia for a dorsal nerve block or ring block. **2. Why the other options are incorrect:** * **Options B & C (With Adrenaline):** These are strictly contraindicated in surgeries involving "appendages" or areas with end-arterial supply (fingers, toes, nose, ears, and penis) due to the risk of ischemic necrosis. * **Option D (2% Lignocaine without Adrenaline):** While "without adrenaline" is correct, 2% lignocaine is generally avoided for routine circumcision blocks because the total dose required to achieve a circumferential block might approach toxic limits more quickly than the 1% concentration, especially in pediatric patients. **Clinical Pearls for NEET-PG:** * **Safe Sites for Adrenaline:** Scalp, trunk, and limbs (excluding digits). * **Maximum Dose of Lignocaine:** 4 mg/kg (without adrenaline) and 7 mg/kg (with adrenaline). * **Nerve Block for Circumcision:** The **Dorsal Penile Nerve Block (DPNB)** is the gold standard. The nerves are located in the sub-fascial space (deep to Buck’s fascia). * **Complication:** If accidental adrenaline injection occurs, the antidote is local infiltration of **Phentolamine** (an alpha-blocker) to induce vasodilation.

Q: ECG changes can first be observed when the level of lignocaine is more than which of the following values?

5-6 ug/ml. ### Explanation Lignocaine (Lidocaine) is an amide local anesthetic that acts by blocking voltage-gated sodium channels. Its toxicity is dose-dependent and follows a predictable progression as plasma concentrations rise, moving from the central nervous system (CNS) to the cardiovascular system (CVS). **1. Why 5–6 µg/ml is correct:** The therapeutic range for lignocaine (e.g., when used as an anti-arrhythmic) is **1.5–5 µg/ml**. Once plasma levels exceed **5 µg/ml**, the drug begins to exert significant inhibitory effects on the cardiac conduction system. Initial ECG changes—such as **PR interval prolongation and QRS widening**—typically manifest at concentrations between **5–10 µg/ml**. **2. Analysis of Incorrect Options:** * **1.2 µg/ml (Option D):** This is below the therapeutic threshold. No toxic effects are observed here. * **2–4 µg/ml (Option C):** This is within the therapeutic range. While mild CNS symptoms (lightheadedness, metallic taste) may begin at the upper end of this range (around 3–5 µg/ml), ECG changes are not yet evident. * **10–12 µg/ml (Option B):** At these high levels, toxicity is severe. This range is associated with profound myocardial depression, bradycardia, AV block, and potentially seizures or coma. **3. Clinical Pearls for NEET-PG:** * **Progression of Toxicity:** CNS symptoms (tinnitus, perioral numbness, seizures) always precede CVS symptoms with lignocaine. This is the opposite of Bupivacaine, where cardiac arrest can occur simultaneously with seizures. * **CC/CNS Ratio:** Lignocaine has a high ratio, meaning it is safer than Bupivacaine (which has a low ratio and is more cardiotoxic). * **Management:** The specific antidote for Local Anesthetic Systemic Toxicity (LAST) is **20% Intravenous Lipid Emulsion (ILE)**. * **Maximum Dose:** 3 mg/kg (plain) and 7 mg/kg (with adrenaline).

Q: It is difficult to obtain local infiltration anesthesia in the presence of inflammation because of which of the following?

A decreased pH. ### Explanation **1. Why "A decreased pH" is correct:** Local anesthetics (LAs) are **weak bases**. In their commercial preparation, they exist in an equilibrium between a non-ionized (lipid-soluble) form and an ionized (water-soluble) form. Only the **non-ionized form** can cross the lipid-rich neuronal membrane to reach its site of action. According to the Henderson-Hasselbalch equation, in an acidic environment (low pH) caused by inflammation (due to the release of lactic acid and inflammatory mediators), the equilibrium shifts toward the **ionized form**. Since ionized molecules cannot penetrate the nerve sheath, the concentration of the drug reaching the axoplasm is significantly reduced, leading to anesthetic failure. **2. Analysis of Incorrect Options:** * **B. Increased vascularity:** While inflammation causes vasodilation which can lead to faster systemic absorption (shorter duration of action), it is not the primary reason for the *failure to achieve* initial anesthesia. * **C. Edema:** Edema may dilute the anesthetic solution slightly, but it does not chemically prevent the drug from entering the nerve. * **D. Pain:** Pain is the symptom resulting from the failure of anesthesia, not the physiological cause of the failure itself. **3. High-Yield NEET-PG Pearls:** * **Mechanism of Action:** LAs block voltage-gated **sodium (Na+) channels** from the *inside* of the cell. * **pKa Relationship:** The closer the pKa of a local anesthetic is to the tissue pH (7.4), the faster the onset of action (e.g., Lidocaine has a lower pKa than Procaine, hence faster onset). * **Sodium Bicarbonate:** Clinicians sometimes add sodium bicarbonate to LAs to raise the pH, increasing the non-ionized fraction and accelerating the onset of the block. * **Infected Tissues:** Never inject directly into an abscess; the acidic environment ensures the block will be ineffective and may spread the infection.

Q: Bupivacaine toxicity causes which of the following?

Cardiotoxicity. **Explanation:** **Bupivacaine** is a long-acting amide local anesthetic (LA) widely used in regional anesthesia. Its most significant and life-threatening side effect is **Cardiotoxicity**, which occurs due to its high affinity for voltage-gated sodium channels in the myocardium. **Why Cardiotoxicity is the Correct Answer:** Bupivacaine binds more tightly and dissociates much more slowly from cardiac sodium channels compared to other LAs (like Lidocaine). This "slow-in, slow-out" kinetic property leads to a prolonged recovery of the cardiac action potential. Clinically, this manifests as severe ventricular arrhythmias (VT/VF), AV block, and profound myocardial depression. Notably, bupivacaine toxicity often presents with a narrow margin between the dose required for CNS toxicity (seizures) and the dose causing cardiovascular collapse. **Why Other Options are Incorrect:** * **Renal Toxicity:** Local anesthetics are primarily metabolized by the liver (amides) or plasma esterases (esters) and excreted by the kidneys, but they do not cause direct nephrotoxicity. * **Pulmonary Toxicity:** While systemic toxicity can lead to respiratory arrest due to CNS depression or paralysis of respiratory muscles (if used in high spinal blocks), bupivacaine is not directly toxic to lung tissue. **High-Yield Clinical Pearls for NEET-PG:** * **Antidote:** The specific treatment for Local Anesthetic Systemic Toxicity (LAST) is **Intravenous Lipid Emulsion (20% Intralipid)**. It acts as a "lipid sink," sequestering the lipophilic bupivacaine from the cardiac tissue. * **R-Isomer vs. S-Isomer:** Bupivacaine is a racemic mixture. Its S-enantiomers, **Levobupivacaine** and **Ropivacaine**, were developed to provide similar analgesic effects with significantly lower cardiotoxicity. * **Pregnancy:** Bupivacaine cardiotoxicity is enhanced in pregnancy due to increased sensitivity of the myocardium.

Q: What is the role of sodium bisulphate in a local anesthetic solution?

Reducing agent. ### Explanation **Correct Option: A (Reducing agent)** Sodium bisulphate (or sodium metabisulphite) is added to local anesthetic (LA) solutions that contain **epinephrine (adrenaline)**. Epinephrine is highly unstable and prone to oxidation, which turns the solution brown and renders it ineffective. Sodium bisulphate acts as an **antioxidant (reducing agent)** by reacting with oxygen before it can oxidize the epinephrine, thereby extending the shelf life and maintaining the potency of the vasoconstrictor. **Analysis of Incorrect Options:** * **B. Aesthetic agent:** This is a distractor; "aesthetic" refers to appearance or beauty and has no pharmacological role in LA solutions. * **C. Vasoconstrictor:** While sodium bisulphate is found in solutions containing vasoconstrictors, it is not the agent itself. Epinephrine and Phenylephrine are the actual vasoconstrictors used to decrease systemic absorption and prolong the block. * **D. Preservative:** While it "preserves" the epinephrine, in pharmacological terms, preservatives (like **Methylparaben**) are specifically added to multi-dose vials to prevent microbial growth. Sodium bisulphate is specifically classified as an antioxidant/reducing agent. **High-Yield Clinical Pearls for NEET-PG:** * **Allergy Alert:** Patients with "sulfite sensitivity" (common in asthmatics) may react to the sodium bisulphate in LA, not the anesthetic drug itself. In such cases, use "plain" LA (without epinephrine). * **pH Changes:** The addition of sodium bisulphate lowers the pH of the solution (makes it more acidic), which can increase the "sting" upon injection and slightly delay the onset of action. * **Hyaluronidase:** Sometimes added to LA to increase the speed of onset and spread (the "spreading factor").

Q: What is observed in systemic local anesthetic toxicity?

Postconvulsion central nervous system depression. ### Explanation **Local Anesthetic Systemic Toxicity (LAST)** occurs due to high plasma concentrations of local anesthetics, primarily affecting the Central Nervous System (CNS) and the Cardiovascular System. **Why Option B is Correct:** The CNS effects of LAST follow a predictable, biphasic progression. Initially, local anesthetics selectively block **inhibitory pathways** (GABAergic neurons) in the cerebral cortex. This "disinhibition" allows excitatory pathways to function unopposed, leading to excitatory symptoms like tremors and **generalized convulsions**. However, as plasma levels continue to rise, the drug eventually blocks **both inhibitory and excitatory pathways**, leading to a state of generalized **post-convulsion CNS depression**. This phase is characterized by respiratory depression, coma, and eventually respiratory arrest. **Analysis of Incorrect Options:** * **Option A:** Convulsions are caused by the blockade of inhibitory pathways (disinhibition), not by postsynaptic depression. * **Option C & D:** While both generalized convulsions and CNS depression occur during toxicity, **Option B** is the most comprehensive answer as it describes the definitive clinical progression and the dangerous end-stage of the toxicity spectrum. **High-Yield Clinical Pearls for NEET-PG:** * **Earliest Sign:** Perioral numbness, metallic taste, and tinnitus. * **Most Cardiotoxic LA:** **Bupivacaine** (due to slow dissociation from cardiac sodium channels—"fast in, slow out" kinetics). * **Treatment of Choice:** **20% Intralipid (Lipid Emulsion Therapy)**. It acts as a "lipid sink," sequestering the lipophilic drug from the plasma. * **Potentiating Factors:** Hypercapnia, acidosis, and hypoxia worsen toxicity by increasing cerebral blood flow and decreasing protein binding.

Q: Which of the following is the LEAST useful treatment for local anesthetic-induced convulsions?

Phenytoin. The correct answer is **Phenytoin**. ### **Explanation** Local anesthetic (LA) induced convulsions are a manifestation of **Local Anesthetic Systemic Toxicity (LAST)**. LAs cross the blood-brain barrier and cause CNS excitation by inhibiting inhibitory pathways. **Why Phenytoin is the LEAST useful:** Phenytoin is ineffective and potentially harmful in the management of LA-induced seizures for two main reasons: 1. **Mechanism of Action:** Phenytoin works by blocking voltage-gated sodium channels. Since local anesthetics already cause profound sodium channel blockade (especially in the heart), adding phenytoin can worsen cardiac toxicity and conduction delays. 2. **Onset of Action:** Phenytoin has a slow onset of action and is not suitable for the acute termination of rapid-onset seizures. **Why the other options are incorrect:** * **Midazolam (Benzodiazepines):** These are the first-line agents for controlling LA-induced seizures. They enhance GABAergic inhibition, raising the seizure threshold. * **Thiopentone & Propofol:** Both are potent anticonvulsants used if benzodiazepines fail. However, they must be used in small doses to avoid worsening the cardiovascular depression often associated with LAST. ### **Clinical Pearls for NEET-PG** * **First Step in Management:** Secure the airway and provide 100% oxygen (hypoxia and acidosis worsen LA toxicity). * **Definitive Treatment for LAST:** **Intravenous Lipid Emulsion (ILE) 20%**. It acts as a "lipid sink," drawing the lipophilic LA out of the tissues. * **Drug to Avoid:** Avoid **Vasopressin** and high-dose Epinephrine during resuscitation in LAST, as they can worsen pulmonary edema and arrhythmias. * **Most Cardiotoxic LA:** Bupivacaine (due to slow dissociation from cardiac sodium channels). * **Least Cardiotoxic LA:** Lidocaine.

Q: Levo-bupivacaine is administered by which of the following routes?

Epidural. **Explanation:** **Levo-bupivacaine** is the S-enantiomer of the amide local anesthetic bupivacaine. It is primarily used for **regional anesthesia**, specifically via the **epidural route**, spinal anesthesia, and peripheral nerve blocks. **Why Epidural is Correct:** Levo-bupivacaine works by blocking sodium channels in nerve fibers, preventing the propagation of action potentials. It is preferred for epidural administration in obstetrics and major surgeries because it provides excellent sensory blockade with a longer duration of action. Crucially, it has a **lower risk of cardiotoxicity and neurotoxicity** compared to racemic bupivacaine, making it a safer profile for high-volume regional blocks. **Why Other Options are Incorrect:** * **Nasogastric:** Local anesthetics are not administered via NG tubes as they are intended for site-specific nerve blockade, not systemic absorption through the GI tract. * **Intravenous:** Intravenous administration of potent local anesthetics like bupivacaine is strictly avoided (except for specific uses of Lidocaine) because it can lead to **Local Anesthetic Systemic Toxicity (LAST)**, resulting in seizures and fatal cardiac arrhythmias. **High-Yield Clinical Pearls for NEET-PG:** * **Safety Profile:** Levo-bupivacaine and Ropivacaine are "pure isomers" developed to reduce the cardiac side effects associated with the R-isomer of bupivacaine. * **Differential Block:** It provides a better "differential block" (sensory block > motor block), which is ideal for "walking epidurals" in labor analgesia. * **Toxicity Management:** If accidental IV injection occurs leading to toxicity, the antidote of choice is **20% Intralipid (Lipid Emulsion Therapy)**.

Question 1

Which of the following is referred to as the 'chemical tourniquet'?

Accepted Answer

Adrenaline

Answer

Hyaluronidase

Answer

Both Adrenaline and Hyaluronidase

Answer

None of the above

Question 2

Which of the following nerve fibers are most susceptible to the action of local anesthetics?

Accepted Answer

C fibers

Answer

A fibers

Answer

B fibers

Answer

D fibers

Question 3

Which of the following local anesthetics is used in circumcision?

Accepted Answer

1% lignocaine without adrenaline

Answer

2% lignocaine with adrenaline

Answer

1% lignocaine with adrenaline

Answer

2% lignocaine without adrenaline

Question 4

ECG changes can first be observed when the level of lignocaine is more than which of the following values?

Accepted Answer

5-6 ug/ml

Answer

10-12 ug/ml

Answer

2-4 ug/ml

Answer

1.2 ug/ml

Question 5

It is difficult to obtain local infiltration anesthesia in the presence of inflammation because of which of the following?

Accepted Answer

A decreased pH

Answer

Increased vascularity

Answer

Edema

Answer

Pain

Question 6

Bupivacaine toxicity causes which of the following?

Accepted Answer

Cardiotoxicity

Answer

Renal toxicity

Answer

Pulmonary toxicity

Answer

None of the above

Question 7

What is the role of sodium bisulphate in a local anesthetic solution?

Accepted Answer

Reducing agent

Answer

Aesthetic agent

Answer

Vasoconstrictor

Answer

Preservative

Question 8

What is observed in systemic local anesthetic toxicity?

Accepted Answer

Postconvulsion central nervous system depression

Answer

Postsynaptic depression leading to convulsions

Answer

Generalized convulsions

Answer

Central nervous system depression

Question 9

Which of the following is the LEAST useful treatment for local anesthetic-induced convulsions?

Accepted Answer

Phenytoin

Answer

Thiopentone

Answer

Midazolam

Answer

Propofol

Question 10

Levo-bupivacaine is administered by which of the following routes?

Accepted Answer

Epidural

Answer

Nasogastric

Answer

Intravenous

Answer

All

Local Anesthetics — MCQs

Local Anesthetics — MCQs

On this page

Practice by Chapter

Want unlimited practice?